Neutralising antibodies for West Nile virus in horses from Brazilian Pantanal.

Authors:
Address: Laboratório de Flavivírus, Instituto Oswaldo Cruz-Fiocruz, Ministério da Saúde, Avenida Brasil 4365, 21045-900 Rio de Janeiro, RJ, Brasil. pauvolid@ioc.fiocruz.br
Journal:

Publication:

abstract

Despite evidence of West Nile virus (WNV) activity in Colombia, Venezuela and Argentina, this virus has not been reported in most South American countries. In February 2009, we commenced an investigation for WNV in mosquitoes, horses and caimans from the Pantanal, Central-West Brazil. The sera of 168 horses and 30 caimans were initially tested using a flaviviruses-specific epitope-blocking enzyme-linked immunosorbent assay (blocking ELISA) for the detection of flavivirus-reactive antibodies. The seropositive samples were further tested using a plaque-reduction neutralisation test (PRNT90) for WNV and its most closely-related flaviviruses that circulate in Brazil to confirm the detection of specific virus-Neutralising antibodies. Of the 93 (55.4%) blocking ELISA-seropositive horse serum samples, five (3%) were seropositive for WNV, nine (5.4%) were seropositive for St. Louis encephalitis virus, 18 (10.7%) were seropositive for Ilheus virus, three (1.8%) were seropositive for Cacipacore virus and none were seropositive for Rocio virus using PRNT90, with a criteria of ≥ four-fold antibody titre difference. All caimans were negative for flaviviruses-specific antibodies using the blocking ELISA. No virus genome was detected from caiman blood or mosquito samples. The present study is the first report of confirmed serological evidence of WNV activity in Brazil.

Related Articles
Epitope-blocking enzyme-linked immunosorbent assay to differentiate west nile virus from Japanese encephalitis virus infections in equine sera.
Clin Vaccine Immunol. 2007
Epitope-blocking enzyme-linked immunosorbent assay to differentiate west nile virus from Japanese encephalitis virus infections in equine sera.
Kitai Y, Shoda M, Kondo T, Konishi E. Clin Vaccine Immunol. 2007 Aug; 14(8):1024-31. Epub 2007 Jun 27.
Recombinant canarypoxvirus vaccine carrying the prM/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge.
Arch Virol Suppl. 2004
Recombinant canarypoxvirus vaccine carrying the prM/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge.
Minke JM, Siger L, Karaca K, Austgen L, Gordy P, Bowen R, Renshaw RW, Loosmore S, Audonnet JC, Nordgren B. Arch Virol Suppl. 2004; (18):221-30.
Seroconversion for West Nile and St. Louis encephalitis viruses among sentinel horses in Colombia.
Mem Inst Oswaldo Cruz. 2011
Seroconversion for West Nile and St. Louis encephalitis viruses among sentinel horses in Colombia.
Mattar S, Komar N, Young G, Alvarez J, Gonzalez M. Mem Inst Oswaldo Cruz. 2011 Dec; 106(8):976-9.
Review West Nile virus infection of horses.
Vet Res. 2004
Review West Nile virus infection of horses.
Castillo-Olivares J, Wood J. Vet Res. 2004 Jul-Aug; 35(4):467-83.
Review West Nile virus activity in Latin America and the Caribbean.
Rev Panam Salud Publica. 2006
Review West Nile virus activity in Latin America and the Caribbean.
Komar N, Clark GG. Rev Panam Salud Publica. 2006 Feb; 19(2):112-7.

To top • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.